Baxter International, Inc.

911 articles with Baxter International, Inc.

• Baxter Launches the Sharesource Analytics 1.0 Digital Health Module to Enhance Clinical Management of Home Dialysis Patients

  6/2/2021

  Next generation digital health module uniquely designed to keep patients on home dialysis by helping identify potential therapy complications Sharesource Analytics will further enhance healthcare professionals’ ability to keep peritoneal dialysis patients safer at home during the COVID-19 pandemic

• Baxter Launches PrisMax 2 System to Advance Critical Care Delivery for Patients and Hospitals

  5/25/2021

  Baxter International Inc., a global leader in acute care, announced the global launch of PrisMax 2, the latest version of the company’s next-generation platform.

• DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology

  5/10/2021

  DaVita Kidney Care announced the expansion of its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis system enabled by Sharesource remote patient monitoring from Baxter International Inc., a global innovator in renal care.

• Baxter to Present at the UBS Global Healthcare Virtual Conference

  5/4/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021.

• Baxter Increases Dividend and Declares Quarterly Dividend - May 03, 2021

  5/3/2021

  Baxter International Inc., a leading global medical products company, announced an increase in the company’s quarterly cash dividend to a rate of $0.28 per share of common stock.

• Baxter Reports First-Quarter 2021 Results

  4/29/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2021.

• Baxter Recognized Globally for Inclusion Efforts

  4/21/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countries for its inclusion efforts.

• Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research

  4/21/2021

  Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF).

• Baxter to Present at the BofA Securities 2021 Virtual Health Care Conference

  4/7/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:45 a.m. Eastern Time.

• Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format - Mar 30, 2021

  3/30/2021

  Baxter International Inc., a leading global medical products company, announced that, due to the public health and safety concerns related to the novel coronavirus pandemic, its Annual Meeting of Stockholders will again be held by means of a virtual format only.

• Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors

  3/24/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thursday, April 29, 2021 at 7:30 a.m. Central Time.

• Baxter Announces U.S. FDA 510(k) Clearance of AK 98 Hemodialysis Machine

  3/12/2021

  Latest technology offers a compact, portable and easy-to-use system for dialysis providers Includes two-way connectivity to securely transfer prescription and treatment data Can be used alongside Theranova , Baxter’s novel dialysis membrane

• Baxter to Present at Oppenheimer 31st Annual Healthcare Conference

  3/10/2021

  Baxter International Inc., a leading global medical products company, will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021.

• Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

  3/8/2021

  Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,

• Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director

  2/16/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia School of Medicine, and co-founder and chief scientific officer of biotech start-up ImmuneWorks to its board of directors.

• Baxter Declares Quarterly Dividend - Feb 16, 2021

  2/16/2021

  Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock.

• Baxter Reports Fourth-Quarter and Full-Year 2020 Results

  2/4/2021

  Baxter Reports Fourth-quarter sales of $3.2 billion increased 5% on a reported basis, 3% on a constant currency basis and 2% on an operational basis 1 Fourth-quarter U.S. GAAP earnings per share (EPS) were $0.33 and adjusted EPS were $0.80 Full-year revenue of $11.7 billion increased 3% on both a reported and constant currency basis and 2% on an operational basis

• Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

  1/11/2021

  Agreement will help increase commercial production and promote access in United Kingdom and European markets Manufacturing to take place at Baxter’s state-of-the-art Halle/Westfalen, Germany facility

• Baxter to Host Fourth-Quarter 2020 Financial Results Conference Call for Investors

  1/5/2021

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time

• Baxter to Present at the 39th Annual J.P. Morgan Healthcare Conference

  12/16/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 11, 2021 at 9:10 a.m. Eastern Time. The live webcast of Baxter’s presentation, along with accompanying slides, can be accessed at www.baxter.com